- Home
- JKHY vs SNN Comparison
JKHY vs SNN Comparison
Compare JKHY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKHY
- SNN
- Stock Information
- Founded
- JKHY 1976
- SNN 1856
- Country
- JKHY United States
- SNN United Kingdom
- Employees
- JKHY N/A
- SNN N/A
- Industry
- JKHY Retail: Computer Software & Peripheral Equipment
- SNN Industrial Specialties
- Sector
- JKHY Technology
- SNN Health Care
- Exchange
- JKHY Nasdaq
- SNN Nasdaq
- Market Cap
- JKHY 12.1B
- SNN 12.7B
- IPO Year
- JKHY N/A
- SNN 1999
- Fundamental
- Price
- JKHY $178.28
- SNN $28.83
- Analyst Decision
- JKHY Hold
- SNN Hold
- Analyst Count
- JKHY 9
- SNN 3
- Target Price
- JKHY $184.22
- SNN $27.50
- AVG Volume (30 Days)
- JKHY 536.6K
- SNN 780.9K
- Earning Date
- JKHY 05-06-2025
- SNN 07-31-2025
- Dividend Yield
- JKHY 1.31%
- SNN 2.58%
- EPS Growth
- JKHY 13.10
- SNN 56.15
- EPS
- JKHY 5.87
- SNN 0.47
- Revenue
- JKHY $2,319,828,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- JKHY $8.37
- SNN $6.87
- Revenue Next Year
- JKHY $6.79
- SNN $5.19
- P/E Ratio
- JKHY $30.26
- SNN $30.62
- Revenue Growth
- JKHY 5.92
- SNN 4.70
- 52 Week Low
- JKHY $158.62
- SNN $23.69
- 52 Week High
- JKHY $196.00
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- JKHY 45.57
- SNN 49.61
- Support Level
- JKHY $178.58
- SNN $28.40
- Resistance Level
- JKHY $181.20
- SNN $30.38
- Average True Range (ATR)
- JKHY 2.70
- SNN 0.36
- MACD
- JKHY -0.38
- SNN -0.17
- Stochastic Oscillator
- JKHY 16.78
- SNN 30.00
About JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for us banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.